Inventor · disambiguated record
Dries De Clercq
Also filed as: DE CLERCQ DRIES
6 granted patents·7 pending applications·5 citations·filing 2018–2021
69Inventor score
Files withDANA FARBER CANCER INST INC13
Top patents by PatentIndex Score
13 records- 0186US10450310B2Bifunctional molecules for degradation of EGFR and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Oct 22, 2019·5 cites·18 claims
- 0268US2022017510A1Bifunctional molecules for degradation of egfr and methods of useDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0367US11161842B2Bifunctional molecules for degradation of EGFR and methods of useDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 2, 2021·0 cites·19 claims
- 0463US11945816B2Inhibitors of EGFR and/or HER2 and methods of useDANA FARBER CANCER INST INC·Filed 2021·Granted Apr 2, 2024·0 cites·16 claims
- 0555US11186574B2Inhibitors of EGFR and/or HER2 and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 30, 2021·0 cites·20 claims
- 0651US12161649B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 10, 2024·0 cites·22 claims
- 0748US2020377501A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0843US11584746B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 21, 2023·0 cites·22 claims
- 0943US2021085688A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1042US2020375999A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1142US2021077469A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1241US2020390783A1Inhibitors of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1341US2020377477A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dries De Clercq files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →